XPhyto (OTC: XPHYF) Engages German Partner for Development of Psilocybin API Production
Research agreement to investigate the feasibility of a proprietary biotechnology process for the industrial production of psilocybin API Psilocybin is designated by the FDA as a breakthrough therapy for severe depression VANCOUVER, BC / November […]
